Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

10/11/2023 06:30

Nov 10 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.50                1.90             2.80     
                   (-21.5 pct)         (+17.3 pct)      (-4.1 pct)  
  Operating       loss 108 mln           501 mln          260 mln   
                                      (+367.6 pct)      (-69.9 pct) 
  Recurring        loss 36 mln           676 mln          242 mln   
                                      (+183.8 pct)      (-73.2 pct) 
  Net             loss 117 mln           467 mln          183 mln   
                                      (+175.9 pct)      (-74.7 pct) 
  EPS             loss 5.45 yen         22.28 yen        8.74 yen   
  EPS Diluted                           22.27 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T